Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of the Immune Response to Herpes Simplex Virus Type 1 (HSV-1) and General Immune Health in Subjects Infected With HSV-1

NCT03661541 is registered in ClinicalTrials.gov with Squarex, LLC as lead sponsor.

NCT NCT03661541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of the Immune Response to Herpes Simplex Virus Type 1 (HSV-1) and General Immune Health in Subjects Infected With HSV-1
Lead sponsor
Squarex, LLC
Phase
Phase 1
Overall status
Completed
Start date
March 2, 2017
Completion date
October 25, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis, hsv